MA52337A - Nouveaux analogues d'oxaborole et utilisations de ces derniers - Google Patents

Nouveaux analogues d'oxaborole et utilisations de ces derniers

Info

Publication number
MA52337A
MA52337A MA052337A MA52337A MA52337A MA 52337 A MA52337 A MA 52337A MA 052337 A MA052337 A MA 052337A MA 52337 A MA52337 A MA 52337A MA 52337 A MA52337 A MA 52337A
Authority
MA
Morocco
Prior art keywords
oxaborole
analogues
latest
new
oxaborole analogues
Prior art date
Application number
MA052337A
Other languages
English (en)
Inventor
Paul Alan Glossop
Robert Toms Jacobs
Delphine Françoise Monique Launay
Yang Liu
Charles Eric Mowbray
Stephen John Robinson
Richard J Sciotti
Jason D Speake
Gavin Alistair Whitlock
Original Assignee
Anacor Pharmaceuticals Inc
Us Gov Sec Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Us Gov Sec Army filed Critical Anacor Pharmaceuticals Inc
Publication of MA52337A publication Critical patent/MA52337A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052337A 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers MA52337A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762465294P 2017-03-01 2017-03-01

Publications (1)

Publication Number Publication Date
MA52337A true MA52337A (fr) 2021-03-03

Family

ID=63370509

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052337A MA52337A (fr) 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers

Country Status (4)

Country Link
US (2) US10961261B2 (fr)
EP (1) EP3609504A4 (fr)
MA (1) MA52337A (fr)
WO (1) WO2018160845A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. Nouveaux analogues d'oxaborole et utilisations de ces derniers
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA
KR20250005365A (ko) 2022-04-28 2025-01-09 니혼노야쿠가부시키가이샤 옥심기를 갖는 함질소 복소환 화합물 및 상기 화합물을 함유하는 농원예용 제초제 및 이들의 사용방법
TR2023001878A1 (tr) * 2023-02-20 2024-08-21 Univ Yeditepe Borun nöronal kaynakli lei̇shmani̇asi̇s hastaliğinin tedavi̇si̇ i̇çi̇n kullanimi
CN118724752B (zh) * 2023-03-29 2025-11-28 重庆博腾制药科技股份有限公司 一种酪氨酸激酶抑制剂中间体、制备方法及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05006685A (es) 2002-12-18 2005-12-14 Anacor Pharmaceuticals Inc Antibioticos que contienen complejos de acido borinico y metodos de uso.
US7465836B2 (en) 2003-06-16 2008-12-16 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
ATE447960T1 (de) 2004-06-14 2009-11-15 Anacor Pharmaceuticals Inc Antivirale verwendung von borinsäurekomplexen
HRP20150710T1 (hr) 2006-02-16 2015-08-14 Anacor Pharmaceuticals, Inc. Male molekule koje sadrže bor kao protu-upalni agensi
BRPI0711155A2 (pt) 2006-05-02 2011-08-23 Anacor Pharmaceuticals Inc terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
WO2007146965A2 (fr) 2006-06-12 2007-12-21 Anacor Pharmaceuticals, Inc. Composés destinés au traitement d'une maladie périodontale
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
EP2187893A4 (fr) 2008-03-06 2012-02-22 Anacor Pharmaceuticals Inc Petites molécules contenant du bore utilisées en tant qu'agents anti-inflammatoires
JP2011515359A (ja) * 2008-03-18 2011-05-19 グラクソ グループ リミテッド 治療用トリアゾールアミド誘導体
US20100256092A1 (en) 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010027975A1 (fr) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
WO2010045503A1 (fr) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore en tant qu’agents antiprotozoaires
WO2010045505A1 (fr) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore en tant qu’agents antiprotozoaires
CN102256494A (zh) 2008-12-17 2011-11-23 阿纳科制药公司 (s)-3-氨甲基-7-(3-羟基-丙氧基)-3h-苯并[c][1,2]氧杂硼杂环戊-1-醇的多晶型物
JP2013500974A (ja) 2009-07-28 2013-01-10 アナコール ファーマシューティカルズ，インコーポレイテッド 三置換ホウ素含有分子
US9440994B2 (en) * 2009-08-14 2016-09-13 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
WO2011022337A1 (fr) 2009-08-19 2011-02-24 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore en tant qu'agents anti-protozoaires
WO2011037731A1 (fr) 2009-09-25 2011-03-31 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
US9346834B2 (en) 2009-10-20 2016-05-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
WO2011060199A1 (fr) 2009-11-11 2011-05-19 Anacor Pharmaceuticals, Inc. Petites molecules contenant du bore
WO2011094450A1 (fr) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Petites molecules contenant du bore
US8623911B2 (en) 2010-03-19 2014-01-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agent
PT3251678T (pt) 2010-09-07 2021-11-22 Anacor Pharmaceuticals Inc Derivados de benzoxaborol para tratamento de infeções bacterianas
WO2012145734A1 (fr) * 2011-04-22 2012-10-26 The Ohio State University Compositions antileshmaniennes et ses méthodes d'utilisation
AR088668A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
AR088669A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
WO2014078802A1 (fr) 2012-11-19 2014-05-22 Irm Llc Composés et compositions pour le traitement de maladies parasitaires
AP2015008638A0 (en) * 2013-02-01 2015-08-31 Anacor Pharmaceuticals Inc Boron-containing small molecules as antiprotozoal agents
WO2015013318A1 (fr) 2013-07-22 2015-01-29 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
EP3609504A4 (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. Nouveaux analogues d'oxaborole et utilisations de ces derniers

Also Published As

Publication number Publication date
EP3609504A4 (fr) 2021-03-03
EP3609504A1 (fr) 2020-02-19
US11691992B2 (en) 2023-07-04
US10961261B2 (en) 2021-03-30
US20210253605A1 (en) 2021-08-19
US20200024289A1 (en) 2020-01-23
WO2018160845A1 (fr) 2018-09-07

Similar Documents

Publication Publication Date Title
EP3615574A4 (fr) Constructions reconnaissant spécifiquement le glypicane 3 et utilisations de ces dernieres
EP3625358A4 (fr) Biomarqueurs et utilisations de ces derniers
MA52337A (fr) Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP3684366A4 (fr) Ligands crbn et utilisations de ces derniers
MA51288A (fr) Analogues d'incrétine et leurs utilisations
MA46180A (fr) Analogues de l'amyline
MA51287A (fr) Analogues d'incrétine et leurs utilisations
EP3661918A4 (fr) Analogues de 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one
MA46589A (fr) Composés et utilisations de ces derniers
EP3595694A4 (fr) Construction de furtif immunitaire cas9 crispr
EP3607587A4 (fr) Panneau d'affichage
EP3689215A4 (fr) Détermination d'attribut de région
EP3615019A4 (fr) Modulateurs de l'interaction sestrine-gator2 et utilisations de ces derniers
EP3580241A4 (fr) Anticorps anti-facteur d et utilisations de ces derniers
MA49847A (fr) Production enzymatique d'hexoses
EP3368663A4 (fr) Lignées cellulaires exemptes de virus et procédés d'obtention de celles-ci
EP3607053A4 (fr) Lymphocytes t spécifiques d'antigènes et utilisations de ces derniers
MA47494A (fr) Nouvelles utilisations d'anticorps anti-sirpg
EP3324894A4 (fr) Prothèse du genou à pivotement latéral et médian
EP3658560A4 (fr) Modulateurs de la somatostatine et utilisations de ces derniers
EP3347334A4 (fr) Déshydrohalogénation d'hydrochlorofluorocarbones
EP3506254A4 (fr) Structure d'insonorisation
EP3436434A4 (fr) Analogues d'indoline et leurs utilisations
EP3303366A4 (fr) Dérivés de dolastatine 10 et utilisations de ceux-ci
EP3710462A4 (fr) Analogues de brartémicine